Trump Executive Order Targets Lower Prescription Drug Prices

President Donald Trump recently signed an executive order aimed at reducing prescription drug prices in the United States.

This policy initiative introduces several measures to overhaul pricing structures, including significant amendments to the Medicare drug price negotiation program. By mandating changes to how Medicare negotiates drug prices, the order seeks to align more closely with prices paid in other countries, potentially leading to substantial cost reductions for U.S. consumers. This move could have broad implications for the healthcare and insurance industries, affecting everything from market pricing strategies to insurance coverage options.